RAPT Therapeutics, Inc. (RAPT) Analyst Forecast

$57.65

$0.04 (0.07%)
Last update: 05:09 AM EST
Day's range
$57.6
Day's range
$57.7

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date
Details
01/21/2026 Leerink Partners Thomas Smith $58.00 $57.57   0.75%
01/20/2026 Wells Fargo Yanan Zhu $58.00 $57.50   0.87%
01/20/2026 H.C. Wainwright Emily Bodnar $58.00 $57.51   0.85%
10/27/2025 Guggenheim Yatin Suneja $70.00 $29.53   137.05%
08/12/2025 UBS Eliana Merle $9.00 $9.47   -4.96%
11/12/2024 Leerink Partners Thomas Smith $2.00 $1.74   14.94%
11/12/2024 Stifel Nicolaus Alex Thompson $2.00 $1.74   14.94%
12/08/2022 Piper Sandler Edward Tenthoff $33.00 $16.48   100.24%
09/21/2022 Capital One Financial Zegbeh Jallah $48.00 $24.17   98.59%

RAPT Therapeutics, Inc. FAQ's

RAPT Therapeutics, Inc. has been rated by research analysts at Barclays, Leerink Partners, Wells Fargo, H.C. Wainwright, Piper Sandler, Guggenheim in the past 90 days.